James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 8,168 shares at $23.69 ($193K) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Open-market sale of $193k ACAD by PRINCIPAL ACCOUNTING OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.69 | 4,084 | $97K | 50.0% |
| 2 | $23.69 | 4,084 | $97K | 50.0% |
| Total | $23.69 avg | 8,168 | $193K | 100% |
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |